Yun Wang

8PUBLICATIONS
13CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsMedical biotechnology diagnostics (incl. biosensors)Nutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 03, 2026
BCMA versus GPRC5D bispecific antibodies in relapsed/refractory multiple myeloma: A systematic review and meta-analysis guiding treatment selection.

|Apr 30, 2026
Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies.

|Aug 01, 2025
The bone marrow immune ecosystem shapes daratumumab acquired resistance in plasma cell myeloma.

Yun Wang, Shuzhao Chen, Zhijian Liang

|May 14, 2024
Elevated serum levels of soluble B-cell maturation antigen as a prognostic biomarker for multiple myeloma.

Pei Guo, Yun Wang, Haiyan He

|Jun 30, 2023
Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trials.

Yuanfang Li, Shuqiang Yuan, Yingbo Chen

|Nov 28, 2022
Prognostic value of the nutritional risk index in patients with newly diagnosed multiple myeloma.

Limei Zhang, Shuzhao Chen, Mayan Huang

Pageof 2

Frequent Collaborators

3 joint publications

Weida Wang

3 joint publications

Yang Liang

2 joint publications

Runcong Nie

2 joint publications

Yuan-Fang Li